114
Views
4
CrossRef citations to date
0
Altmetric
Articles

PTPN22 Gene Polymorphisms in Pediatric Systemic Lupus Erythematosus

, , , , ORCID Icon, , ORCID Icon, & ORCID Icon show all
Pages 13-20 | Received 30 Apr 2019, Accepted 28 May 2019, Published online: 24 Jun 2019

References

  • Sabahi R, Anolik JH. B-cell-targeted therapy for systemic lupus erythematosus. Drugs. 2006;66(15):1933–48. doi: 10.2165/00003495-200666150-00004.
  • Palagini L, Mosca M, Tani C, et al. Depression and systemic lupus erythematosus: a systematic review. Lupus. 2013;22(5):409–16. doi: 10.1177/0961203313477227.
  • Stichweh D, Arce E, Pascual V. Update on pediatric systemic lupus erythematosus. Curr Opin Rheumatol. 2004;16(5):577–87. doi: 10.1097/01.bor.0000137852.42270.0f.
  • Danchenko N, Satia J, Anthony M. Epidemiology of systemic lupus erythematosus: a comparison of worldwide disease burden. Lupus. 2006;15(5):308–18. doi: 10.1191/0961203306lu2305xx.
  • Akbarian M, Faezi ST, Gharibdoost F, et al. Systemic lupus erythematosus in Iran: a study of 2280 patients over 33 years. Int J Rheum Dis. 2010;13(4):374–79. doi: 10.1111/j.1756-185X.2010.01547.x.
  • Midgley A, McLaren Z, Moots RJ, et al. The role of neutrophil apoptosis in juvenile‐onset systemic lupus erythematosus. Arthritis Rheumatol. 2009;60(8):2390–401. doi: 10.1002/art.24634.
  • Tahghighi F, Ziaee V, Moradinejad MH, et al. Tumor necrosis factor-alpha single nucleotide polymorphisms in juvenile systemic lupus erythematosus. Hum Immunol. 2015;76(8):533–6. doi: 10.1016/j.humimm.2015.06.011.
  • Ziaee V, Tahghighi F, Moradinejad MH, et al. Interleukin-6, interleukin-1 gene cluster and interleukin-1 receptor polymorphisms in Iranian patients with juvenile systemic lupus erythematosus. Eur Cytokine Netw. 2014;25(2):35–40.
  • Harsini S, Ziaee V, Tahghighi F, et al. Association of interleukin-2 and interferon-γ single nucleotide polymorphisms with Juvenile systemic lupus erythematosus. Allergol Immunopath. 2016;44(5):422–6. doi: 10.1016/j.aller.2015.12.005.
  • Mahmoudi M, Tahghighi F, Ziaee V, et al. Interleukin‐4 single nucleotide polymorphisms in juvenile systemic lupus erythematosus. Int J Immunogenet. 2014;41(6):512–7. doi: 10.1111/iji.12152.
  • Rianthavorn P, Chokedeemeeboon C, Deekajorndech T, et al. Interleukin-10 promoter polymorphisms and expression in Thai children with juvenile systemic lupus erythematosus. Lupus. 2013;22(7):721–6. doi: 10.1177/0961203313486192.
  • Namjou B, Kim-Howard X, Sun C, et al. PTPN22 association in systemic lupus erythematosus (SLE) with respect to individual ancestry and clinical sub-phenotypes. PloS one. 2013;8(8):e69404.
  • Zamani MR, Aslani S, Salmaninejad A, et al. PD-1/PD-L and autoimmunity: a growing relationship. Cell Immunol. 2016;310:27–41. doi: 10.1016/j.cellimm.2016.09.009.
  • Ladner MB, Bottini N, Valdes AM, et al. Association of the single nucleotide polymorphism C1858T of the PTPN22 gene with type 1 diabetes. Hum Immunol. 2005;66(1):60–4. doi: 10.1016/j.humimm.2004.09.016.
  • Bahrami T, Soltani S, Moazzami K, et al. Association of PTPN22 gene polymorphisms with susceptibility to juvenile idiopathic arthritis in Iranian population. Fetal Pediatr Pathol. 2017;36(1):42–8. doi: 10.1080/15513815.2016.1231249.
  • Aslani S, Mahmoudi M, Salmaninejad A, et al. Lack of association between STAT4 single nucleotide polymorphisms and Iranian juvenile rheumatoid arthritis patients. Fetal Pediatr Pathol. 2017;36(3):177–83. doi: 10.1080/15513815.2016.1253809.
  • Tang L, Wang Y, Zheng S, et al. PTPN22 polymorphisms, but not R620W, were associated with the genetic susceptibility of systemic lupus erythematosus and rheumatoid arthritis in a Chinese Han population. Hum Immunol. 2016;77(8):692–8. doi: 10.1016/j.humimm.2016.04.021.
  • Diaz-Gallo LM, Gourh P, Broen J, et al. Analysis of the influence of PTPN22 gene polymorphisms in systemic sclerosis. Ann Rheum Dis. 2011;70(3):454–62. doi: 10.1136/ard.2010.130138.
  • Hill RJ, Zozulya S, Lu Y-L, et al. The lymphoid protein tyrosine phosphatase Lyp interacts with the adaptor molecule Grb2 and functions as a negative regulator of T-cell activation. Exp Hematol. 2002;30(3):237–44. doi: 10.1016/S0301-472X(01)00794-9.
  • Bottini N, Musumeci L, Alonso A, et al. A functional variant of lymphoid tyrosine phosphatase is associated with type I diabetes. Nat Genet. 2004;36(4):337. doi: 10.1038/ng1323.
  • Carlton VEH, Hu X, Chokkalingam AP, et al. PTPN22 genetic variation: evidence for multiple variants associated with rheumatoid arthritis. Am J Hum Genet. 2005;77(4):567–81. doi: 10.1086/468189.
  • Hinks A, Barton A, John S, et al. Association between the PTPN22 gene and rheumatoid arthritis and juvenile idiopathic arthritis in a UK population: further support that PTPN22 is an autoimmunity gene. Arthritis Rheum. 2005;52(6):1694–9. doi: 10.1002/art.21049.
  • Rodríguez‐Rodríguez L, Taib WRW, Topless R, et al. The PTPN22 R263Q polymorphism is a risk factor for rheumatoid arthritis in Caucasian case–control samples. Arthritis Rheumatol. 2011;63(2):365–72. doi: 10.1002/art.30145.
  • Smith RL, Warren RB, Eyre S, et al. Polymorphisms in the PTPN22 region are associated with psoriasis of early onset. British J Dermatol. 2008;158(5):962–8. doi: 10.1111/j.1365-2133.2008.08482.x.
  • Taniyama M, Maruyama T, Tozaki T, et al. Association of PTPN22 haplotypes with type 1 diabetes in the Japanese population. Hum Immunol. 2010;71(8):795–8. doi: 10.1016/j.humimm.2010.05.016.
  • Ban Y, Tozaki T, Taniyama M, et al. Association of the protein tyrosine phosphatase nonreceptor 22 haplotypes with autoimmune thyroid disease in the Japanese population. Thyroid. 2010;20(8):893–9. doi: 10.1089/thy.2010.0104.
  • Chinoy H, Platt H, Lamb J, et al. The protein tyrosine phosphatase N22 gene is associated with juvenile and adult idiopathic inflammatory myopathy independent of the HLA 8.1 haplotype in British Caucasian patients. Arthritis Rheumatol. 2008;58(10):3247–54. doi: 10.1002/art.23900.
  • Dieude P, Guedj M, Wipff J, et al. The PTPN22 620W allele confers susceptibility to systemic sclerosis: findings of a large case–control study of European Caucasians and a meta‐analysis. Arthritis Rheumatol. 2008;58(7):2183–8. doi: 10.1002/art.23601.
  • Martín J-E, Alizadeh BZ, González-Gay MA, et al. Evidence for PTPN22 R620W polymorphism as the sole common risk variant for rheumatoid arthritis in the 1p13. 2 region. J Rheumatol. 2011;38(11):2290–6. doi: 10.3899/jrheum.110361.
  • Xue L, Pan C, Gu Z, et al. Genetic heterogeneity of susceptibility gene in different ethnic populations: refining association study of PTPN22 for Graves’ disease in a Chinese Han population. PloS One. 2013;8(12):e84514. doi: 10.1371/journal.pone.0084514.
  • Curtin K, Wong J, Allen-Brady K, et al. Meta-genetic association of rheumatoid arthritis and PTPN22 using PedGenie 2.1. BMC Proc. 2007;1:S12. doi: 10.1186/1753-6561-1-s1-s12.
  • Piotrowski P, Lianeri M, Wudarski M, et al. Contribution of the R620W polymorphism of protein tyrosine phosphatase non-receptor 22 to systemic lupus erythematosus in Poland. Clin Exp Rheumatol. 2008;26(6):1099–102.
  • Reddy MV, Johansson M, Sturfelt G, et al. The R620W C/T polymorphism of the gene PTPN22 is associated with SLE independently of the association of PDCD1. Genes Immun. 2005;6(8):658–62. doi: 10.1038/sj.gene.6364252.
  • Zoledziewska M, Perra C, Orru V, et al. Further evidence of a primary, causal association of the PTPN22 620W variant with type 1 diabetes. Diabetes. 2008;57(1):229–34. doi: 10.2337/db07-0289.
  • Smyth D, Cooper JD, Collins JE, et al. Replication of an association between the lymphoid tyrosine phosphatase locus (LYP/PTPN22) with type 1 diabetes, and evidence for its role as a general autoimmunity locus. Diabetes. 2004;53(11):3020–3. doi: 10.2337/diabetes.53.11.3020.
  • LaBerge GS, Bennett DC, Fain PR, et al. PTPN22 is genetically associated with risk of generalized vitiligo, but CTLA4 is not. J Investig Dermatol. 2008;128(7):1757–62. doi: 10.1038/sj.jid.5701233.
  • Hashemi M, Atabaki M, Daneshvar H, et al. Association of PTPN22 rs2476601 and EGFR rs17337023 Gene polymorphisms and rheumatoid arthritis in Zahedan, Southeast Iran. Int J Immunogenet. 2013;40(4):299–305. doi: 10.1111/iji.12038.
  • Viken M, Amundsen S, Kvien T, et al. Association analysis of the 1858C > T polymorphism in the PTPN22 gene in juvenile idiopathic arthritis and other autoimmune diseases. Genes Immun. 2005;6(3):271. doi: 10.1038/sj.gene.6364178.
  • Todd JA, Walker NM, Cooper JD, et al. Robust associations of four new chromosome regions from genome-wide analyses of type 1 diabetes. Nat Genet. 2007;39(7):857–64. doi: 10.1038/ng2068.
  • Harrison P, Pointon JJ, Farrar C, et al. Effects of PTPN22 C1858T polymorphism on susceptibility and clinical characteristics of British Caucasian rheumatoid arthritis patients. Rheumatology. 2006;45(8):1009–111. doi: 10.1093/rheumatology/kei250.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.